E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/28/2008 in the Prospect News Convertibles Daily.

Nabi repurchases $38.8 million of 2.875% convertible senior notes

By Devika Patel

Knoxville, Tenn., Feb. 28 - Nabi Biopharmaceuticals said in a press release it has bought back $38.8 million of its 2.875% convertible senior notes for $34.1 million, a $4.7 million discount.

Nabi is a Boca Raton, Fla.-based biotech firm.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.